Dr Elizabeth Ann Courson, OD | |
289 Ireland Ave, Irach Optometry Clinic, Fort Knox, KY 40121-5111 | |
(502) 624-9663 | |
Not Available |
Full Name | Dr Elizabeth Ann Courson |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 10 Years |
Location | 289 Ireland Ave, Fort Knox, Kentucky |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144622390 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | OEG002976 (Pennsylvania) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Kentucky Eyecare And Wellness, Llc | 4688061476 | 3 |
News Archive
In one of the first studies of its kind, medical and engineering researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
The reason why some people find it so hard to resist finishing an entire bag of chips or bowl of candy may lie with how their brain responds to food rewards, leaving them more vulnerable to overeating.
Cerus Corporation announced today that it has received a $2.1 million award from the U.S. Department of Defense to support the advanced development of the company's technology for inactivating pathogens and leukocytes in red blood cells.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The meeting will be held April 17-21, 2010 in Washington, DC.
› Verified 8 days ago
Provider Name | John F Simpson Jr Psc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1780875880 PECOS PAC ID: 6406847029 Enrollment ID: O20040521000951 |
News Archive
In one of the first studies of its kind, medical and engineering researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
The reason why some people find it so hard to resist finishing an entire bag of chips or bowl of candy may lie with how their brain responds to food rewards, leaving them more vulnerable to overeating.
Cerus Corporation announced today that it has received a $2.1 million award from the U.S. Department of Defense to support the advanced development of the company's technology for inactivating pathogens and leukocytes in red blood cells.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The meeting will be held April 17-21, 2010 in Washington, DC.
› Verified 8 days ago
Provider Name | Central Kentucky Eyecare And Wellness, Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1104587591 PECOS PAC ID: 4688061476 Enrollment ID: O20220426001173 |
News Archive
In one of the first studies of its kind, medical and engineering researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
The reason why some people find it so hard to resist finishing an entire bag of chips or bowl of candy may lie with how their brain responds to food rewards, leaving them more vulnerable to overeating.
Cerus Corporation announced today that it has received a $2.1 million award from the U.S. Department of Defense to support the advanced development of the company's technology for inactivating pathogens and leukocytes in red blood cells.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The meeting will be held April 17-21, 2010 in Washington, DC.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Elizabeth Ann Courson, OD 289 Ireland Ave, Irach Optometry Clinic, Fort Knox, KY 40121-5111 Ph: () - | Dr Elizabeth Ann Courson, OD 289 Ireland Ave, Irach Optometry Clinic, Fort Knox, KY 40121-5111 Ph: (502) 624-9663 |
News Archive
In one of the first studies of its kind, medical and engineering researchers have shown wearable devices that continuously monitor blood sugar provide new insights into the progression of Type 2 diabetes among at-risk Hispanic/Latino adults.
The reason why some people find it so hard to resist finishing an entire bag of chips or bowl of candy may lie with how their brain responds to food rewards, leaving them more vulnerable to overeating.
Cerus Corporation announced today that it has received a $2.1 million award from the U.S. Department of Defense to support the advanced development of the company's technology for inactivating pathogens and leukocytes in red blood cells.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The meeting will be held April 17-21, 2010 in Washington, DC.
› Verified 8 days ago
Exceptional Eye Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 127 Gold Vault Rd, Fort Knox, KY 40121 Phone: 502-799-1675 Fax: 502-799-1674 | |
Dr. Marie G Edling, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 127 Gold Vault Rd # 127, Fort Knox, KY 40121 Phone: 502-799-1675 Fax: 502-799-1675 |